SGMT Earnings & Financial Statements
Sagimet Biosciences Inc.
$8.90
+$0.14(+1.60%)
44
Overall
60
Value
45
Tech
28
Quality
Market Cap
$617.87M
Volume
397.81K
52W Range
$4.50 - $11.45
Target Price
$26.62
SGMT earnings and financial statements: Sagimet Biosciences Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
SGMT Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | - | - | $2.00M | - | - |
| Operating income | -$56.89M | -$54.45M | -$30.74M | -$31.05M | - |
| EBITDA | -$51.04M | -$45.57M | -$27.88M | - | - |
| Net income | -$51.04M | -$45.57M | -$27.88M | -$30.50M | - |
| EPS (diluted) | $-1.58 | $-1.45 | $-2.66 | $-165.20 | - |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $116.48M | $160.26M | $96.72M | $33.03M | - |
| Total liabilities | $5.10M | $4.45M | $5.65M | $219.98M | - |
| Shareholders’ equity | $111.38M | $155.81M | $91.06M | -$186.95M | - |
| Cash and equivalents | $35.02M | $75.84M | $75.14M | $158.0K | - |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$45.65M | -$42.44M | -$23.77M | -$24.49M | - |
| Free cash flow | -$45.65M | -$42.44M | -$23.77M | -$24.49M | -$21.71M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SGMT | $8.90 | +1.6% | 397.81K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Sagimet Biosciences Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW